イタリア - イタリア語 - Ministero della Salute

vetviva richter gmbh - metamizolo sodico, butilbromuro di joscina - metamizolo sodico - 500 milligrammi/millilitro (mg/ml); butilbromuro di joscina - 4 milligrammo (i), metamizolo sodico - 500 mg/ml; n-butilbromuro di joscina - 4 mg/ml, n-butilbromuro di joscina - 4 mg/ml; metamizolo sodico - 500 mg/ml - butylscopolamine and analgesics

イタリア - イタリア語 - Ministero della Salute

fatro s.p.a. - detomidina cloridrato - detomidina cloridrato - 10 mg/ml - detomidine

イタリア - イタリア語 - Ministero della Salute

dechra regulatory b.v. - metamizolo sodico - metamizolo sodico - nd - butylscopolamine and analgesics

イタリア - イタリア語 - AIFA (Agenzia Italiana del Farmaco)

hikma farmaceutica (portugal) s.a. - adenosina - adenosina

欧州連合 - イタリア語 - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabete mellito, tipo 2 - farmaci usati nel diabete - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , triplice terapia di associazione) in aggiunta alla dieta e all'esercizio fisico in pazienti non adeguatamente controllati il loro dosaggio massimo tollerato di metformina ed una sulfonilurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

イタリア - イタリア語 - AIFA (Agenzia Italiana del Farmaco)

amdipharm ltd - ergotamina, associazioni escl. psicolettici - ergotamina, associazioni escl. psicolettici

イタリア - イタリア語 - AIFA (Agenzia Italiana del Farmaco)

promedica s.r.l. - ipratropio bromuro - ipratropio bromuro

イタリア - イタリア語 - AIFA (Agenzia Italiana del Farmaco)

cheplapharm arzneimittel gmbh - acebutololo - acebutololo

イタリア - イタリア語 - AIFA (Agenzia Italiana del Farmaco)

merck serono s.p.a. - levotiroxina sodica - levotiroxina sodica

イタリア - イタリア語 - AIFA (Agenzia Italiana del Farmaco)

i.b.n. savio s.r.l - atenololo e altri diuretici - atenololo e altri diuretici